Sep 07, 2016 11:01 am UTC| Business
Unite Cellular Immunotherapy Expertise to Accelerate Clinical Translation ofOff-the-Shelf Products Offering Broad Patient Access Collaboration to Use Engineered Pluripotent Cell Lines to Renewably GenerateT-Cell Product...
Apricus Biosciences to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Sep 07, 2016 11:00 am UTC| Business
SAN DIEGO, Sept. 07, 2016 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief Executive Officer,...
Sep 07, 2016 11:00 am UTC| Business
NEW YORK and KISSING, Germany, Sept. 07, 2016 -- invendo medical GmbH, a leading developer and distributor of sterile, single-use and robotically-assisted HD endoscopy products in the field of gastroenterology and GI...
Akoustis™ Expands IP - Signs Exclusive License Agreement with Cornell University
Sep 07, 2016 11:00 am UTC| Business
Charlotte, N.C., Sept. 07, 2016 -- Akoustis Technologies, Inc. (OTCQB: AKTS) (“Akoustis” or the “Company”), a manufacturer of innovative BulkONE™ bulk acoustic wave (BAW) high-band RF filters for mobile wireless,...
Sep 07, 2016 11:00 am UTC| Business
CARMIEL, Israel, Sept. 07, 2016 -- Protalix BioTherapeutics, Inc.(NYSE MKT:PLX) (TASE:PLX), announced today an oral presentation highlighting the results of the phase I/II clinical trial of PRX-102 for the treatment of...
Sep 07, 2016 11:00 am UTC| Business
PLEASANTON, Calif., Sept. 07, 2016 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference in...
Summit Therapeutics to Present at 18th Annual Rodman & Renshaw Global Investment Conference
Sep 07, 2016 11:00 am UTC| Business
OXFORD, United Kingdom, Sept. 07, 2016 -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and Clostridium difficile...